LBEL - 13537-501-02 - (Titanium Dioxide, Zinc Oxide, and Octinoxate)

Alphabetical Index


Drug Information of LBEL

Product NDC: 13537-501
Proprietary Name: LBEL
Non Proprietary Name: Titanium Dioxide, Zinc Oxide, and Octinoxate
Active Ingredient(s): .03; .062393; .049    g/g; g/g; g/g & nbsp;   Titanium Dioxide, Zinc Oxide, and Octinoxate
Administration Route(s): TOPICAL
Dosage Form(s): POWDER
Coding System: National Drug Codes(NDC)

Labeler Information of LBEL

Product NDC: 13537-501
Labeler Name: Ventura Corporation LTD.
Product Type: HUMAN OTC DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20130527

Package Information of LBEL

Package NDC: 13537-501-02
Package Description: 1 CARTRIDGE in 1 BOX (13537-501-02) > 10 g in 1 CARTRIDGE (13537-501-01)

NDC Information of LBEL

NDC Code 13537-501-02
Proprietary Name LBEL
Package Description 1 CARTRIDGE in 1 BOX (13537-501-02) > 10 g in 1 CARTRIDGE (13537-501-01)
Product NDC 13537-501
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Titanium Dioxide, Zinc Oxide, and Octinoxate
Dosage Form Name POWDER
Route Name TOPICAL
Start Marketing Date 20130527
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name Ventura Corporation LTD.
Substance Name OCTINOXATE; TITANIUM DIOXIDE; ZINC OXIDE
Strength Number .03; .062393; .049
Strength Unit g/g; g/g; g/g
Pharmaceutical Classes

Complete Information of LBEL


General Information